Category: Edwards Lifesciences
Jason Rupp, former AdvaMed executive is named executive director for Southeastern Medical Device Association (SEMDA).
The Southeastern Medical Device Association (SEMDA) has named former AdvaMed executive Jason Rupp as its first full time executive director.
Edwards Lifesciences is flush with cash after a solid 2014, but is more likely to spend on share buybacks than acquisitions, CFO Scott Ullem tells analysts.
Edwards Lifesciences boosts its outlook for 2015 after reporting soaring profits for the 4th quarter.
Patients who've already had coronary artery bypass graft surgery showed a significant mortality benefit with Medtronic's CoreValve replacement heart valve than with open heart surgery, according to a clinical trial.
MassDevice.com asks medical device CEOs about the key issues of 2014 and what's ahead for the New Year.
As 2014 draws to a close, MassDevice.com asked several medical device company CEOs for their takes on 2014 and what they're looking for in 2015.
We wanted to get their views on the major trends seen in medtech this year, including the red-hot M&A and IPO scenes, the medical device tax, the regulatory environment in the U.S., and more.
Here's a look at some of the top legal news stories for medical device companies this week: CardioKinetix raises $50m, inks buyout deal with Edwards Lifesciences; Angel Medical raises $10m for ischemia devices; Zyga Technology raises $2m; Image Stream Medical looks at $8m
A clinical study delivers positive results for replacement heart valves made by rivals Edwards Lifesciences and Medtronic in treating bicuspid disease.